Details of the Drug Inactive Ingredient (DIG)
Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG | ||||||
---|---|---|---|---|---|---|
ICD Disease Classification 01 | Infectious/parasitic disease | Click to Show/Hide | ||||
Minocycline
|
API Info |
Streptococcus bacterial infection [ICD-11: 1C41]
|
[1] | |||
Metronidazole
|
API Info |
Amebiasis [ICD-11: 1A36]
|
[2] | |||
Oseltamivir
|
API Info |
Influenza virus infection [ICD-11: 1E30]
|
[3] | |||
Tetracycline
|
API Info |
Spotted fever [ICD-11: 1C31]
|
[4] | |||
Famciclovir
|
API Info |
Genital herpes [ICD-11: 1A94]
|
[5] | |||
Ethambutol
|
API Info |
Pulmonary tuberculosis [ICD-11: 1B10]
|
[6] | |||
Isoniazid
|
API Info |
Pulmonary tuberculosis [ICD-11: 1B10]
|
[7] | |||
Ciprofloxacin
|
API Info |
Endocarditis [ICD-11: 1B12]
|
[8] | |||
Mebendazole
|
API Info |
Ascariasis [ICD-11: 1F62]
|
[9] | |||
Pyrazinamide
|
API Info |
Pulmonary tuberculosis [ICD-11: 1B10]
|
[10] | |||
Valganciclovir
|
API Info |
Cytomegalovirus infection [ICD-11: 1D82]
|
[11] | |||
Sulfadiazine
|
API Info |
Toxoplasmosis [ICD-11: 1F57]
|
[12] | |||
ICD Disease Classification 02 | Benign/in-situ/malignant neoplasm | Click to Show/Hide | ||||
Temozolomide
|
API Info |
Brain cancer [ICD-11: 2A00]
|
[13] | |||
Nicotinic acid
|
API Info |
Lung cancer [ICD-11: 2C25]
|
[14] | |||
Mercaptopurine
|
API Info |
Acute lymphoblastic leukemia [ICD-11: 2B33]
|
[15] | |||
Nystatin
|
API Info |
Acute lymphoblastic leukemia [ICD-11: 2B33]
|
[16] | |||
Chlorambucil
|
API Info |
Chronic lymphocytic leukaemia [ICD-11: 2A82]
|
[17] | |||
Thioguanine
|
API Info |
Acute myeloid leukemia [ICD-11: 2A60]
|
[18] | |||
Cabozantinib
|
API Info |
Thyroid cancer [ICD-11: 2D10]
|
[19] | |||
ICD Disease Classification 04 | Immune system disease | Click to Show/Hide | ||||
Methylprednisolone
|
API Info |
Systemic lupus erythematosus [ICD-11: 4A40]
|
[20] | |||
ICD Disease Classification 05 | Endocrine/nutritional/metabolic disease | Click to Show/Hide | ||||
Phentermine
|
API Info |
Obesity [ICD-11: 5B81]
|
[21] | |||
Potassium chloride
|
API Info |
Hypokalemia [ICD-11: 5C77]
|
[22] | |||
Glipizide
|
API Info |
Diabetes mellitus [ICD-11: 5A10]
|
[23] | |||
Metformin
|
API Info |
Diabetes mellitus [ICD-11: 5A10]
|
[24] | |||
Phendimetrazine
|
API Info |
Obesity [ICD-11: 5B81]
|
[25] | |||
Fenofibric acid
|
API Info |
Dyslipidaemia [ICD-11: 5C81]
|
[26] | |||
Folic acid
|
API Info |
Vitamin deficiency [ICD-11: 5B55]
|
[27] | |||
Liothyronine
|
API Info |
Hypothyroidism [ICD-11: 5A00]
|
[28] | |||
Sodium bicarbonate
|
API Info |
Metabolic acidosis [ICD-11: 5C73]
|
[29] | |||
Pyridoxine
|
API Info |
Vitamin deficiency [ICD-11: 5B55]
|
[30] | |||
Trientine
|
API Info |
Hyperphosphatemia [ICD-11: 5C64]
|
[31] | |||
ICD Disease Classification 06 | Mental/behavioural/neurodevelopmental disorder | Click to Show/Hide | ||||
Risperidone
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[32] | |||
Bupropion
|
API Info |
Nicotine dependence [ICD-11: 6C4A]
|
[33] | |||
Lamotrigine
|
API Info |
Bipolar disorder [ICD-11: 6A60]
|
[34] | |||
Fluoxetine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[35] | |||
Hydroxyzine
|
API Info |
Anxiety disorder [ICD-11: 6B00]
|
[36] | |||
Methylphenidate
|
API Info |
Attention deficit hyperactivity disorder [ICD-11: 6A05]
|
[37] | |||
Guanfacine
|
API Info |
Attention deficit hyperactivity disorder [ICD-11: 6A05]
|
[38] | |||
Lithium carbonate
|
API Info |
Bipolar disorder [ICD-11: 6A60]
|
[39] | |||
Imipramine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[40] | |||
Prochlorperazine
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[41] | |||
Desipramine
|
API Info |
Attention deficit hyperactivity disorder [ICD-11: 6A05]
|
[42] | |||
Trazodone
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[43] | |||
Paliperidone
|
API Info |
Bipolar disorder [ICD-11: 6A60]
|
[44] | |||
Carisoprodol
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[45] | |||
Amphetamine
|
API Info |
Attention deficit hyperactivity disorder [ICD-11: 6A05]
|
[46] | |||
Meprobamate
|
API Info |
Anxiety disorder [ICD-11: 6B00]
|
[47] | |||
Disulfiram
|
API Info |
Alcohol dependence [ICD-11: 6C40]
|
[48] | |||
Amoxapine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[49] | |||
Methamphetamine
|
API Info |
Attention deficit hyperactivity disorder [ICD-11: 6A05]
|
[50] | |||
ICD Disease Classification 07 | Sleep-wake disorder | Click to Show/Hide | ||||
Dextroamphetamine
|
API Info |
Narcolepsy [ICD-11: 7A20]
|
[51] | |||
Zolpidem
|
API Info |
Insomnia [ICD-11: 7A00]
|
[52] | |||
Zaleplon
|
API Info |
Insomnia [ICD-11: 7A00]
|
[53] | |||
Estazolam
|
API Info |
Insomnia [ICD-11: 7A00]
|
[54] | |||
ICD Disease Classification 08 | Nervous system disease | Click to Show/Hide | ||||
Acetaminophen
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[55] | |||
Morphine
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[56] | |||
Oxycodone
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[57] | |||
Valproic acid
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[58] | |||
Propranolol
|
API Info |
Migraine [ICD-11: 8A80]
|
[59] | |||
Levetiracetam
|
API Info |
Focal seizure [ICD-11: 8A68]
|
[60] | |||
Carbamazepine
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[61] | |||
Tizanidine
|
API Info |
Tic disorder [ICD-11: 8A05]
|
[62] | |||
Hydromorphone
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[63] | |||
Zonisamide
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[64] | |||
Rivastigmine
|
API Info |
Alzheimer disease [ICD-11: 8A20]
|
[65] | |||
Meperidine
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[66] | |||
Tiagabine
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[67] | |||
Primidone
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[68] | |||
Carprofen
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[69] | |||
Chlorthalidone
|
API Info |
Huntington disease [ICD-11: 8A01]
|
[70] | |||
Codeine
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[71] | |||
Rasagiline
|
API Info |
Parkinsonism [ICD-11: 8A00]
|
[72] | |||
Methylergonovine
|
API Info |
Migraine [ICD-11: 8A80]
|
[73] | |||
Phenobarbital
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[74] | |||
Pyridostigmine
|
API Info |
Myasthenia gravis [ICD-11: 8C60]
|
[75] | |||
Selegiline
|
API Info |
Parkinsonism [ICD-11: 8A00]
|
[76] | |||
Methadone
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[77] | |||
Ticlopidine
|
API Info |
Cerebral stroke [ICD-11: 8B11]
|
[78] | |||
Ethotoin
|
API Info |
Focal seizure [ICD-11: 8A68]
|
[79] | |||
Dihydroergotamine
|
API Info |
Migraine [ICD-11: 8A80]
|
[80] | |||
Levorphanol
|
API Info |
Cerebral stroke [ICD-11: 8B11]
|
[81] | |||
ICD Disease Classification 09 | Visual system disease | Click to Show/Hide | ||||
Pilocarpine
|
API Info |
Glaucoma [ICD-11: 9C61]
|
[82] | |||
ICD Disease Classification 10 | Ear/mastoid process disease | Click to Show/Hide | ||||
Diphenhydramine
|
API Info |
Meniere disease [ICD-11: AB31]
|
[83] | |||
ICD Disease Classification 11 | Circulatory system disease | Click to Show/Hide | ||||
Diltiazem
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[84] | |||
Aspirin
|
API Info |
Myocardial infarction [ICD-11: BA41]
|
[85] | |||
Hydralazine
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[86] | |||
Losartan
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[87] | |||
Enalapril
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[88] | |||
Caffeine
|
API Info |
Orthostatic hypotension [ICD-11: BA21]
|
[89] | |||
Captopril
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[90] | |||
Amlodipine
|
API Info |
Angina pectoris [ICD-11: BA40]
|
[91] | |||
Propafenone
|
API Info |
Ventricular tachyarrhythmia [ICD-11: BC71]
|
[92] | |||
Sotalol
|
API Info |
Atrial fibrillation [ICD-11: BC81]
|
[93] | |||
Benazepril
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[94] | |||
Spironolactone
|
API Info |
Congestive heart failure [ICD-11: BD10]
|
[95] | |||
Digoxin
|
API Info |
Cardiac arrhythmia [ICD-11: BC65]
|
[96] | |||
Amiodarone
|
API Info |
Ventricular tachyarrhythmia [ICD-11: BC71]
|
[97] | |||
Furosemide
|
API Info |
Congestive heart failure [ICD-11: BD10]
|
[98] | |||
Isosorbide dinitrate
|
API Info |
Angina pectoris [ICD-11: BA40]
|
[99] | |||
Dipyridamole
|
API Info |
Atherosclerosis [ICD-11: BA80]
|
[100] | |||
Acebutolol
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[101] | |||
Olmesartan
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[102] | |||
Prasugrel
|
API Info |
Myocardial infarction [ICD-11: BA41]
|
[103] | |||
Flecainide
|
API Info |
Ventricular tachyarrhythmia [ICD-11: BC71]
|
[92] | |||
Betaxolol
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[104] | |||
ICD Disease Classification 12 | Respiratory system disease | Click to Show/Hide | ||||
Guaifenesin
|
API Info |
Asthma [ICD-11: CA23]
|
[105] | |||
Clarithromycin
|
API Info |
Pneumocystis pneumonia [ICD-11: CA40]
|
[106] | |||
Chlorpheniramine
|
API Info |
Allergic rhinitis [ICD-11: CA08]
|
[107] | |||
Fexofenadine
|
API Info |
Allergic rhinitis [ICD-11: CA08]
|
[108] | |||
Promethazine
|
API Info |
Allergic rhinitis [ICD-11: CA08]
|
[109] | |||
Loratadine
|
API Info |
Allergic rhinitis [ICD-11: CA08]
|
[110] | |||
Budesonide
|
API Info |
Allergic rhinitis [ICD-11: CA08]
|
[111] | |||
Clemastine
|
API Info |
Allergic rhinitis [ICD-11: CA08]
|
[112] | |||
Salbutamol
|
API Info |
Chronic obstructive pulmonary disease [ICD-11: CA22]
|
[113] | |||
Dexbrompheniramine
|
API Info |
Allergic rhinitis [ICD-11: CA08]
|
[114] | |||
ICD Disease Classification 13 | Digestive system disease | Click to Show/Hide | ||||
Doxycycline
|
API Info |
Periodontal disease [ICD-11: DA0C]
|
[115] | |||
Bisacodyl
|
API Info |
Irritable bowel syndrome [ICD-11: DD91]
|
[116] | |||
Pantoprazole
|
API Info |
Gastro-oesophageal reflux disease [ICD-11: DA22]
|
[117] | |||
Meclizine
|
API Info |
Functional nausea/vomiting [ICD-11: DD90]
|
[118] | |||
Simethicone
|
API Info |
Irritable bowel syndrome [ICD-11: DD91]
|
[119] | |||
Bismuth subsalicylate
|
API Info |
Irritable bowel syndrome [ICD-11: DD91]
|
[120] | |||
Dicyclomine
|
API Info |
Irritable bowel syndrome [ICD-11: DD91]
|
[121] | |||
Metoclopramide
|
API Info |
Gastro-oesophageal reflux disease [ICD-11: DA22]
|
[122] | |||
Rabeprazole
|
API Info |
Gastro-oesophageal reflux disease [ICD-11: DA22]
|
[123] | |||
Mesalamine
|
API Info |
Inflammatory bowel disease [ICD-11: DD72]
|
[124] | |||
Dimenhydrinate
|
API Info |
Functional nausea/vomiting [ICD-11: DD90]
|
[125] | |||
Mycophenolic acid
|
API Info |
Crohn disease [ICD-11: DD70]
|
[126] | |||
ICD Disease Classification 14 | Skin disease | Click to Show/Hide | ||||
Hydrochlorothiazide
|
API Info |
Luid retention [ICD-11: EF02]
|
[127] | |||
Pseudoephedrine
|
API Info |
Erythema multiforme [ICD-11: EB12]
|
[128] | |||
ICD Disease Classification 15 | Musculoskeletal/connective-tissue disease | Click to Show/Hide | ||||
Naproxen
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[129] | |||
Indomethacin
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[130] | |||
Diclofenac
|
API Info |
Knee osteoarthritis [ICD-11: FA01]
|
[131] | |||
Etodolac
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[132] | |||
Phenylephrine
|
API Info |
Juvenile rheumatoid arthritis [ICD-11: FA24]
|
[133] | |||
Methocarbamol
|
API Info |
Paget's disease [ICD-11: FB85]
|
[134] | |||
Prednisone
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[135] | |||
Allopurinol
|
API Info |
Uncontrolled gout [ICD-11: FA25]
|
[136] | |||
Dexamethasone
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[137] | |||
Metaxalone
|
API Info |
Myalgia [ICD-11: FB56]
|
[138] | |||
Sulindac
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[139] | |||
Azathioprine
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[140] | |||
Ibandronic acid
|
API Info |
Osteoporosis [ICD-11: FB83]
|
[141] | |||
Oxaprozin
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[142] | |||
Sulfasalazine
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[143] | |||
ICD Disease Classification 16 | Genitourinary system disease | Click to Show/Hide | ||||
Ibuprofen
|
API Info |
Dysmenorrhea [ICD-11: GA34]
|
[144] | |||
Terazosin
|
API Info |
Prostatic hyperplasia [ICD-11: GA90]
|
[145] | |||
Erythromycin
|
API Info |
Pelvic inflammatory disease [ICD-11: GA05]
|
[146] | |||
Tolterodine
|
API Info |
Overactive bladder [ICD-11: GC50]
|
[147] | |||
Sevelamer
|
API Info |
Chronic kidney disease [ICD-11: GB61]
|
[148] | |||
Danazol
|
API Info |
Endometriosis [ICD-11: GA10]
|
[149] | |||
Aminocaproic acid
|
API Info |
Menorrhagia [ICD-11: GA20]
|
[150] | |||
Trospium
|
API Info |
Overactive bladder [ICD-11: GC50]
|
[151] | |||
Potassium citrate
|
API Info |
Urinary calculus [ICD-11: GB70]
|
[152] | |||
Tranexamic acid
|
API Info |
Excessive bleeding [ICD-11: GA30]
|
[153] | |||
Trimethoprim
|
API Info |
Infectious cystitis [ICD-11: GC00]
|
[154] | |||
ICD Disease Classification 20 | Developmental anomaly | Click to Show/Hide | ||||
Estradiol
|
API Info |
Turner syndrome [ICD-11: LD50]
|
[155] | |||
Full List of Biological Targets of DIG (DBTs) Regulated by This DIG | ||||||
---|---|---|---|---|---|---|
G-protein coupled receptor (GPCR) | ||||||
DBT Name: Adenosine receptor A3 (AA3R) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 10 uM (tested by experiment) | [156] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | AA3R_HUMAN | |||||
Oxidoreductase (ORase) | ||||||
DBT Name: Prostaglandin G/H synthase 1 (COX-1) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 > 500000 nM (tested by experiment) | [157] | ||||
Tested Species | Bos taurus (Bovine) | |||||
UniProt ID | PGH1_BOVIN | |||||
DBT Name: Prostaglandin G/H synthase 2 (COX-2) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 > 500000 nM (tested by experiment) | [157] | ||||
Tested Species | Ovis aries (Sheep) | |||||
UniProt ID | PGH2_SHEEP | |||||
Hydrolase (HDase) | ||||||
DBT Name: Phosphodiesterase 3A (PDE3A) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 3.1 uM (tested by experiment) | [156] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | PDE3A_HUMAN | |||||
DBT Name: Phosphodiesterase 4D (PDE4D) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 6.7 uM (tested by experiment) | [156] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | PDE4D_HUMAN | |||||
Nuclear receptor (NR) | ||||||
DBT Name: Estrogen receptor alpha (ESR1) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 16 uM (tested by experiment) | [156] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | ESR1_HUMAN | |||||
DBT Name: PPAR-alpha (PPARA) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 1100 nM (tested by experiment) | [158] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | PPARA_HUMAN | |||||
DBT Name: PPAR-delta (PPARD) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 6000 nM (tested by experiment) | [158] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | PPARD_HUMAN | |||||
DBT Name: PPAR-gamma (PPARG) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 30000 nM (tested by experiment) | [158] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | PPARG_HUMAN | |||||
Cell line (CELL) | ||||||
DBT Name: Colon cancer COLO 205 cells (COLO 205) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 > 200000 nM (tested by experiment) | [159] | ||||
Tested Species | Homo sapiens (Human) | |||||
Cellosaurus ID | CVCL_0218 | |||||
DBT Name: Colon cancer HT-29 cells (HT-29) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 > 200000 nM (tested by experiment) | [159] | ||||
Tested Species | Homo sapiens (Human) | |||||
Cellosaurus ID | CVCL_0320 | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.